Posted in | News

DSM, EBRABIOTECH to Introduce New Series of Bio-Based Materials

Royal DSM is an international Life and Material Sciences company. Its U.S-based Business Unit, DSM Functional Materials, has entered into partnership with Empresa Brasileira de Biotechnologia (Ebrabiotech) of Brazil, in order to launch a new array of bio-based materials, branded by DSM.

The concrete floor coatings market utilizes these materials. Its objective is to develop bio-based castor oil materials, which are non-edible and capable of reducing the total carbon footprint.

The DSM Functional Materials were established on DSM's four global growth criteria including Sustainability, Innovation, High-Growth Economies, and Acquisitions and Partnerships. It is intending to gain market acceptance by fabricating its materials to be lightweight and also eco-friendly. The UVolve Instant Floor Coatings, based on UV-curable technology, were introduced in 2009.

According to the Business Unit Director DSM Functional Materials, Henk-Jan Koenen, this new development that has been achieved through DSM and Ebrabiotech is ideal for the production of new green chemistry approaches that deliver sustainable solutions for worldwide marketers. DSM is committed to offering innovative products, with planet, people and profit as its foremost priority.

The development of ECO+ products will contribute to the company’s, capturing more than 80% of its innovation channel by 2015. This novel product line, as a whole, offers environmental benefits that challenge the mainstream solutions.

The industrial concrete flooring market will be benefitted, following the launch of the new line of bio-based materials produced by DSM and Ebrabiotech. Nevertheless, the two companies together anticipate developing sustainable novel low-carbon footprint solutions for structural steel protection applications and aquaculture.

Source: http://www.dsm.com/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). DSM, EBRABIOTECH to Introduce New Series of Bio-Based Materials. AZoBuild. Retrieved on November 22, 2024 from https://www.azobuild.com/news.aspx?newsID=14831.

  • MLA

    Scanlon, Joel. "DSM, EBRABIOTECH to Introduce New Series of Bio-Based Materials". AZoBuild. 22 November 2024. <https://www.azobuild.com/news.aspx?newsID=14831>.

  • Chicago

    Scanlon, Joel. "DSM, EBRABIOTECH to Introduce New Series of Bio-Based Materials". AZoBuild. https://www.azobuild.com/news.aspx?newsID=14831. (accessed November 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. DSM, EBRABIOTECH to Introduce New Series of Bio-Based Materials. AZoBuild, viewed 22 November 2024, https://www.azobuild.com/news.aspx?newsID=14831.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.